PUBLISHER: KBV Research | PRODUCT CODE: 1335968
PUBLISHER: KBV Research | PRODUCT CODE: 1335968
North America Allergy Immunotherapy Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Treatment Type, By Allergy Type, By Country and Growth Forecast, 2023 - 2030
The North America Allergy Immunotherapy Market would witness market growth of 8.1% CAGR during the forecast period (2023-2030).
There are three primary categories of allergy immunotherapy products currently in use: sublingual allergy immunotherapy (SLIT), subcutaneous allergy immunotherapy (SCIT)/injection, and oral allergy immunotherapy. Among them, SLIT offers therapy without injections instead of taking medications for allergies. The United States Food & Drug Administration (FDA) has approved tablets used in the SLIT treatment to treat allergies brought on by grass pollen, ragweed, and dust mites. However, SLIT only treats one particular allergen and does not prevent people from becoming allergic to other things.
It offers SCIT treatment a benefit because it concurrently delays the onset of asthma and other allergies. SCIT is thought to be the most effective type of allergy immunotherapy. The increasing demand for efficient combating techniques is projected to propel the market on a healthy growth trajectory as individuals worldwide become more sensitive to various allergens.
Due to the rising incidence of allergies, the rising desire for individualized medication, and the creation of novel and cutting-edge allergy immunotherapy solutions, the market has seen substantial expansion in recent years. Additionally, sublingual immunotherapy (SLIT)'s growing popularity supports market expansion. In this increasingly recent method of allergy immunotherapy, allergens are given sublingually rather than systemically.
According to the Canadian government, 850,000 children under 14 and more than 3.8 million adults in Canada suffer from asthma. The third-most prevalent chronic illness in Canada is asthma. Allergic asthma, which was more prevalent in male patients and was less frequently appropriately diagnosed at admission or had required prior hospitalization, is connected to the younger average age. Between 2010 and 2018, 379 individuals died in Mexican hospitals, at a mortality rate of 4.32 per 1000 hospital admissions. The market in this region will grow due to the rise in allergic asthma cases. The high prevalence of asthma in the region indicates the growth prospects for regional market.
The US market dominated the North America Allergy Immunotherapy Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $616.9 million by 2030. The Canada market is estimated to witness a CAGR of 10.6% during (2023 - 2030). Additionally, The Mexico market would showcase a CAGR of 9.6% during (2023 - 2030).
Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy. Based on Treatment Type, the market is segmented into Subcutaneous Immunotherapy (SCIT), and Sublingual Immunotherapy (SLIT) (Tablets, and Drops). Based on Allergy Type, the market is segmented into Allergic Rhinitis, Allergic Asthma, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris, Inc. (Mylan N.V.), Merck KGaA , NIOX Group plc , DMS Imaging SA, Adamis Pharmaceuticals Corporation, Stallergenes Greer International AG (B-Flexion), Allergy Therapeutics plc , DBV Technologies S.A., HAL Allergy B.V. (Droege International Group AG.), LETI Pharma, S.L.U.
Scope of the Study
Market Segments covered in the Report:
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
By Treatment Type
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
- Tablets
- Drops
By Allergy Type
- Allergic Rhinitis
- Allergic Asthma
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Viatris, Inc. (Mylan N.V.)
- Merck KGaA
- NIOX Group plc
- DMS Imaging SA
- Adamis Pharmaceuticals Corporation
- Stallergenes Greer International AG (B-Flexion)
- Allergy Therapeutics plc
- DBV Technologies S.A.
- HAL Allergy B.V. (Droege International Group AG.)
- LETI Pharma, S.L.U.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Allergy Immunotherapy Market, by Distribution Channel
- 1.4.2 North America Allergy Immunotherapy Market, by Treatment Type
- 1.4.3 North America Allergy Immunotherapy Market, by Allergy Type
- 1.4.4 North America Allergy Immunotherapy Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market At a Glance
- 2.1 Key Highlight
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Forces Analysis
Chapter 4. North America Allergy Immunotherapy Market by Distribution Channel
- 4.1 North America Retail Pharmacy Market by Country
- 4.2 North America Hospital Pharmacy Market by Country
- 4.3 North America Online Pharmacy Market by Country
Chapter 5. North America Allergy Immunotherapy Market by Treatment Type
- 5.1 North America Subcutaneous Immunotherapy (SCIT) Market by Country
- 5.2 North America Sublingual Immunotherapy (SLIT) Market by Country
- 5.3 North America Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 5.3.1 North America Tablets Market by Country
- 5.3.2 North America Drops Market by Country
Chapter 6. North America Allergy Immunotherapy Market by Allergy Type
- 6.1 North America Allergic Rhinitis Market by Country
- 6.2 North America Allergic Asthma Market by Country
- 6.3 North America Others Market by Country
Chapter 7. North America Allergy Immunotherapy Market by Country
- 7.1 US Allergy Immunotherapy Market
- 7.1.1 US Allergy Immunotherapy Market by Distribution Channel
- 7.1.2 US Allergy Immunotherapy Market by Treatment Type
- 7.1.2.1 US Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 7.1.3 US Allergy Immunotherapy Market by Allergy Type
- 7.2 Canada Allergy Immunotherapy Market
- 7.2.1 Canada Allergy Immunotherapy Market by Distribution Channel
- 7.2.2 Canada Allergy Immunotherapy Market by Treatment Type
- 7.2.2.1 Canada Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 7.2.3 Canada Allergy Immunotherapy Market by Allergy Type
- 7.3 Mexico Allergy Immunotherapy Market
- 7.3.1 Mexico Allergy Immunotherapy Market by Distribution Channel
- 7.3.2 Mexico Allergy Immunotherapy Market by Treatment Type
- 7.3.2.1 Mexico Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 7.3.3 Mexico Allergy Immunotherapy Market by Allergy Type
- 7.4 Rest of North America Allergy Immunotherapy Market
- 7.4.1 Rest of North America Allergy Immunotherapy Market by Distribution Channel
- 7.4.2 Rest of North America Allergy Immunotherapy Market by Treatment Type
- 7.4.2.1 Rest of North America Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
- 7.4.3 Rest of North America Allergy Immunotherapy Market by Allergy Type
Chapter 8. Company Profiles
- 8.1 Viatris, Inc. (Mylan N.V.)
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
- 8.2 Merck KGaA
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
- 8.3 NIOX Group plc
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 SWOT Analysis
- 8.4 DMS Imaging SA
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 SWOT Analysis
- 8.5 Adamis Pharmaceuticals Corporation
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Research & Development Expenses
- 8.5.4 SWOT Analysis
- 8.6 Stallergenes Greer International AG (B-Flexion)
- 8.6.1 Company Overview
- 8.6.2 Recent strategies and developments:
- 8.6.2.1 Partnerships, Collaborations, and Agreements:
- 8.6.2.2 Acquisition and Mergers:
- 8.6.3 SWOT Analysis
- 8.7 Allergy Therapeutics plc
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
- 8.8 DBV Technologies S.A.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Research & Development Expenses
- 8.8.4 SWOT Analysis
- 8.9 HAL Allergy B.V. (Droege International Group AG.)
- 8.9.1 Company Overview
- 8.9.2 SWOT Analysis
- 8.10. LETI Pharma, S.L.U.
- 8.10.1 Company Overview
LIST OF TABLES
- TABLE 1 North America Allergy Immunotherapy Market, 2019 - 2022, USD Million
- TABLE 2 North America Allergy Immunotherapy Market, 2023 - 2030, USD Million
- TABLE 3 North America Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 4 North America Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 5 North America Retail Pharmacy Market by Country, 2019 - 2022, USD Million
- TABLE 6 North America Retail Pharmacy Market by Country, 2023 - 2030, USD Million
- TABLE 7 North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
- TABLE 8 North America Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
- TABLE 9 North America Online Pharmacy Market by Country, 2019 - 2022, USD Million
- TABLE 10 North America Online Pharmacy Market by Country, 2023 - 2030, USD Million
- TABLE 11 North America Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
- TABLE 12 North America Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
- TABLE 13 North America Subcutaneous Immunotherapy (SCIT) Market by Country, 2019 - 2022, USD Million
- TABLE 14 North America Subcutaneous Immunotherapy (SCIT) Market by Country, 2023 - 2030, USD Million
- TABLE 15 North America Sublingual Immunotherapy (SLIT) Market by Country, 2019 - 2022, USD Million
- TABLE 16 North America Sublingual Immunotherapy (SLIT) Market by Country, 2023 - 2030, USD Million
- TABLE 17 North America Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
- TABLE 18 North America Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
- TABLE 19 North America Tablets Market by Country, 2019 - 2022, USD Million
- TABLE 20 North America Tablets Market by Country, 2023 - 2030, USD Million
- TABLE 21 North America Drops Market by Country, 2019 - 2022, USD Million
- TABLE 22 North America Drops Market by Country, 2023 - 2030, USD Million
- TABLE 23 North America Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
- TABLE 24 North America Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
- TABLE 25 North America Allergic Rhinitis Market by Country, 2019 - 2022, USD Million
- TABLE 26 North America Allergic Rhinitis Market by Country, 2023 - 2030, USD Million
- TABLE 27 North America Allergic Asthma Market by Country, 2019 - 2022, USD Million
- TABLE 28 North America Allergic Asthma Market by Country, 2023 - 2030, USD Million
- TABLE 29 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 30 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 31 North America Allergy Immunotherapy Market by Country, 2019 - 2022, USD Million
- TABLE 32 North America Allergy Immunotherapy Market by Country, 2023 - 2030, USD Million
- TABLE 33 US Allergy Immunotherapy Market, 2019 - 2022, USD Million
- TABLE 34 US Allergy Immunotherapy Market, 2023 - 2030, USD Million
- TABLE 35 US Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 36 US Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 37 US Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
- TABLE 38 US Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
- TABLE 39 US Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
- TABLE 40 US Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
- TABLE 41 US Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
- TABLE 42 US Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
- TABLE 43 Canada Allergy Immunotherapy Market, 2019 - 2022, USD Million
- TABLE 44 Canada Allergy Immunotherapy Market, 2023 - 2030, USD Million
- TABLE 45 Canada Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 46 Canada Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 47 Canada Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
- TABLE 48 Canada Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
- TABLE 49 Canada Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
- TABLE 50 Canada Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
- TABLE 51 Canada Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
- TABLE 52 Canada Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
- TABLE 53 Mexico Allergy Immunotherapy Market, 2019 - 2022, USD Million
- TABLE 54 Mexico Allergy Immunotherapy Market, 2023 - 2030, USD Million
- TABLE 55 Mexico Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 56 Mexico Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 57 Mexico Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
- TABLE 58 Mexico Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
- TABLE 59 Mexico Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
- TABLE 60 Mexico Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
- TABLE 61 Mexico Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
- TABLE 62 Mexico Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
- TABLE 63 Rest of North America Allergy Immunotherapy Market, 2019 - 2022, USD Million
- TABLE 64 Rest of North America Allergy Immunotherapy Market, 2023 - 2030, USD Million
- TABLE 65 Rest of North America Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 66 Rest of North America Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 67 Rest of North America Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
- TABLE 68 Rest of North America Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
- TABLE 69 Rest of North America Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
- TABLE 70 Rest of North America Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
- TABLE 71 Rest of North America Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
- TABLE 72 Rest of North America Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
- TABLE 73 key information - Viatris, Inc.
- TABLE 74 key Information - Merck KGaA
- TABLE 75 Key Information - NIOX Group plc
- TABLE 76 Key Information - DMS Imaging SA
- TABLE 77 Key Information - Adamis Pharmaceuticals Corporation
- TABLE 78 Key Information - Stallergenes Greer International AG
- TABLE 79 Key Information - Allergy Therapeutics plc
- TABLE 80 Key Information - DBV TECHNOLOGIES S.A.
- TABLE 81 Key Information - HAL Allergy B.V.
- TABLE 82 Key Information - LETI Pharma, S.L.U.
List of Figures
- FIG 1 Methodology for the research
- FIG 2 North America Allergy Immunotherapy Market, 2019 - 2030, USD Million
- FIG 3 Key Factors Impacting the Allergy Immunotherapy Market
- FIG 4 Porter's Five Forces Analysis - Allergy Immunotherapy Market
- FIG 5 North America Allergy Immunotherapy Market share by Distribution Channel, 2022
- FIG 6 North America Allergy Immunotherapy Market share by Distribution Channel, 2030
- FIG 7 North America Allergy Immunotherapy Market by Distribution Channel, 2019 - 2030, USD Million
- FIG 8 North America Allergy Immunotherapy Market share by Treatment Type, 2022
- FIG 9 North America Allergy Immunotherapy Market share by Treatment Type, 2030
- FIG 10 North America Allergy Immunotherapy Market by Treatment Type, 2019 - 2030, USD Million
- FIG 11 North America Allergy Immunotherapy Market share by Allergy Type, 2022
- FIG 12 North America Allergy Immunotherapy Market share by Allergy Type, 2030
- FIG 13 North America Allergy Immunotherapy Market by Allergy Type, 2019 - 2030, USD Million
- FIG 14 North America Allergy Immunotherapy Market share by Country, 2022
- FIG 15 North America Allergy Immunotherapy Market share by Country, 2030
- FIG 16 North America Allergy Immunotherapy Market by Country, 2019 - 2030, USD Million
- FIG 17 SWOT Analysis: Viatris, Inc.
- FIG 18 Swot Analysis: Merck KGaA
- FIG 19 SWOT Analysis: NIOX Group plc
- FIG 20 SWOT Analysis: DMS Imaging SA
- FIG 21 SWOT Analysis: Adamis Pharmaceuticals Corporation
- FIG 22 Recent strategies and developments: Stallergenes Greer International AG
- FIG 23 SWOT Analysis: Stallergenes Greer International AG
- FIG 24 SWOT Analysis: Allergy Therapeutics plc
- FIG 25 SWOT Analysis: DBV Technologies S.A.
- FIG 26 SWOT Analysis: HAL Allergy B.V.
